- Date: May 26, 2017
- MediaTiC Building
- Carrer de Roc Boronat, 117,
- 08018 Barcelona
- show map
Eurecat, the Technology Centre of Catalonia, organises a seminar on Technological Feasibility Studies. The event, with the collaboration of Nielsen and HealthCluster, will take place on Friday, 26 May at the Sala Cibernàrium of the MediaTiC building and is intended for companies across all sectors which create their own products. During the seminar, they can discover how to expedite their innovation and new concept evaluation processes.
According to Eurecat, the idea for the event took root when the organisation detected the need to expedite the validation processes for new ideas, in order to increase the innovative capacity of companies in Catalonia. In today’s competitive environment, the ability to systematically create multiple ideas based on new concepts, as well as the possibility of testing them in a timely and cost-effective manner, is vital for companies.
During the seminar, participants will see how technology feasibility studies and checks to try out new ideas are conducted—with regard to methodology—and using case examples.
The event will feature presentations by renowned professionals such as José Antonio Gago (Market Manager Product Innovation & Design Thinking at Eurecat), Xavier Plantà (Industrial Technologies Manager at Eurecat), Ana Barrio (Innovation Business Partner at Nielsen), Irene Ràfols (Head of the Product Innovation Unit of Eurecat), Santi Pérez (R&D Engineer at the Product Innovation Unit of Eurecat), Felip Miralles (Head of the eHealth Unit of Eurecat), Roger Font (Head of the Sustainability Unit of Eurecat) and Patricia Arcos (Director of the +PIME Programme of Eurecat).
MediaTiC Building, Barcelona
May 14, 2018
The conference programme includes presentations and networking opportunities, and last year featured participants from 24 different countries.
April 23, 2018
BioVaria allows transfer professionals and spin-offs to present their innovations to representatives from the pharmaceutical industry and potential investors.
April 23, 2018
The conference is a meeting point between innovative companies in the life sciences industry, executives from large pharmaceutical companies, and representatives from investment funds.